Matches in Wikidata for { <http://www.wikidata.org/entity/Q37698957> ?p ?o ?g. }
- Q37698957 description "article científic" @default.
- Q37698957 description "article scientifique" @default.
- Q37698957 description "articolo scientifico" @default.
- Q37698957 description "artigo científico" @default.
- Q37698957 description "artículu científicu espublizáu en 2014" @default.
- Q37698957 description "bilimsel makale" @default.
- Q37698957 description "scientific article published on 08 January 2014" @default.
- Q37698957 description "vedecký článok" @default.
- Q37698957 description "vetenskaplig artikel" @default.
- Q37698957 description "videnskabelig artikel" @default.
- Q37698957 description "vědecký článek" @default.
- Q37698957 description "wetenschappelijk artikel" @default.
- Q37698957 description "wissenschaftlicher Artikel" @default.
- Q37698957 description "наукова стаття, опублікована в січні 2014" @default.
- Q37698957 description "научни чланак" @default.
- Q37698957 description "مقالة علمية نشرت في 08 يناير 2014" @default.
- Q37698957 name "Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models" @default.
- Q37698957 name "Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models" @default.
- Q37698957 name "Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models" @default.
- Q37698957 type Item @default.
- Q37698957 label "Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models" @default.
- Q37698957 label "Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models" @default.
- Q37698957 label "Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models" @default.
- Q37698957 prefLabel "Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models" @default.
- Q37698957 prefLabel "Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models" @default.
- Q37698957 prefLabel "Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models" @default.
- Q37698957 P1433 Q37698957-9853FC82-9032-4825-BCAD-54CC719DA7CE @default.
- Q37698957 P1476 Q37698957-00D101BE-0686-4423-B480-5F12C73EEE04 @default.
- Q37698957 P2093 Q37698957-54B8A5E7-2D58-4E06-A2EC-1702F6C69CE7 @default.
- Q37698957 P2093 Q37698957-5C3FF607-A58B-4E3E-A5FD-0F644C742E00 @default.
- Q37698957 P2093 Q37698957-7217A60B-FAE1-431E-B4EC-3151C2164AAA @default.
- Q37698957 P2093 Q37698957-7DF9A357-4CA7-4136-9D8B-62CC14EE8521 @default.
- Q37698957 P2093 Q37698957-88DC225D-B791-4F5F-A8B8-20228304C7A2 @default.
- Q37698957 P2093 Q37698957-8958AA79-25C2-4D70-A8A6-E75EC7A8D154 @default.
- Q37698957 P2093 Q37698957-977A9167-0697-4D45-908F-0725F9980FA8 @default.
- Q37698957 P2093 Q37698957-B768BB49-1680-4E75-9944-20E7D5AAB5C7 @default.
- Q37698957 P2860 Q37698957-1A3F12CF-867B-4560-A323-E98F278B1181 @default.
- Q37698957 P2860 Q37698957-1B50E880-6CC4-41A8-A522-1BC1749F8D35 @default.
- Q37698957 P2860 Q37698957-1C393A19-22EF-4FB7-9402-C863C1114A0E @default.
- Q37698957 P2860 Q37698957-21207ED5-E1C9-47AB-A369-38A16EF6275D @default.
- Q37698957 P2860 Q37698957-222F5000-0042-4BAA-BC4F-9697E4B57C82 @default.
- Q37698957 P2860 Q37698957-23F63B93-6141-4711-A38A-4AAED618D92F @default.
- Q37698957 P2860 Q37698957-26414596-9F36-4B2F-8CB7-21EA1B7F8F13 @default.
- Q37698957 P2860 Q37698957-28666107-4EEB-4096-A153-1AAADD8E692A @default.
- Q37698957 P2860 Q37698957-2F767FE4-04AA-4027-B638-6866F5A478D4 @default.
- Q37698957 P2860 Q37698957-414BF549-BAE9-4E4C-89B9-A3A4B021830D @default.
- Q37698957 P2860 Q37698957-4A497F0E-716D-4F77-9FD4-91958F9E8093 @default.
- Q37698957 P2860 Q37698957-55244E91-0D9F-439A-8A5A-40E8FD278A6B @default.
- Q37698957 P2860 Q37698957-57B2001B-8FB6-4C3D-9065-8823A9B33B70 @default.
- Q37698957 P2860 Q37698957-5F34486C-D4A1-4AC3-8DE5-53D742A2E279 @default.
- Q37698957 P2860 Q37698957-6DD552D2-C5D5-426A-A97F-335E36DC1F0A @default.
- Q37698957 P2860 Q37698957-705CF099-A15C-4EC8-B7ED-58906524B8D5 @default.
- Q37698957 P2860 Q37698957-720DB195-5369-4660-BDC8-926ACB5C8033 @default.
- Q37698957 P2860 Q37698957-7E2330A2-F432-45CB-A28F-A42633082D11 @default.
- Q37698957 P2860 Q37698957-8195F8A5-90BF-4B4A-A09A-5DE9D00BF552 @default.
- Q37698957 P2860 Q37698957-86150E07-9668-4027-B4DA-1C0AEBC8915C @default.
- Q37698957 P2860 Q37698957-88D3CF56-5CD2-4DC7-8A99-3629528EDA82 @default.
- Q37698957 P2860 Q37698957-8AD1DF7A-9B96-489C-A208-91AF64A4714E @default.
- Q37698957 P2860 Q37698957-8FE55F41-6814-432F-BA2C-777F14758163 @default.
- Q37698957 P2860 Q37698957-AC78629C-3472-476B-A07C-4646C086C299 @default.
- Q37698957 P2860 Q37698957-B06794FB-5548-4370-ACEC-FBCFABB11701 @default.
- Q37698957 P2860 Q37698957-B54FD1A6-CB6F-4DF4-B99A-946F0B4BCC90 @default.
- Q37698957 P2860 Q37698957-B9D2A21A-477B-407B-86FE-51DD5F4C297D @default.
- Q37698957 P2860 Q37698957-BA12C62E-F6FE-44AB-A50B-C4B1C32F1306 @default.
- Q37698957 P2860 Q37698957-BE398629-7135-47E8-92A4-1BDFE2A6F8AE @default.
- Q37698957 P2860 Q37698957-C0DEB977-D7BF-40C3-B91B-F25E6A8FB177 @default.
- Q37698957 P2860 Q37698957-C240992A-1073-4B13-8F61-3EC8FD6EA6D0 @default.
- Q37698957 P2860 Q37698957-CD5477AB-CF7D-444C-8E33-A5C97232687B @default.
- Q37698957 P2860 Q37698957-D149E718-03AB-47E1-977F-AA18FBE47E5C @default.
- Q37698957 P2860 Q37698957-D35F0F01-3A21-45FB-BE99-DDD6FFB3D1ED @default.
- Q37698957 P2860 Q37698957-DBE4F009-5E67-4697-A39A-923EE7E57B88 @default.
- Q37698957 P2860 Q37698957-E26D686B-F3B4-442E-A1BF-531EE870459E @default.
- Q37698957 P2860 Q37698957-E3D8CE5B-AA3D-4CBF-9B08-BE0FAFE42375 @default.
- Q37698957 P2860 Q37698957-E49E706B-ECD5-42D9-96D4-968B42C18515 @default.
- Q37698957 P2860 Q37698957-ED2C8CD7-D46A-4CBA-BE0D-670B5FE7FA10 @default.
- Q37698957 P2860 Q37698957-F1EF1788-AA36-486A-BC22-A5717D8219B0 @default.
- Q37698957 P2860 Q37698957-F80E3F42-3D72-4C7B-B7B3-7372C258249D @default.
- Q37698957 P2860 Q37698957-F99464BF-67A0-4D58-932A-00492EFF3A0D @default.
- Q37698957 P2860 Q37698957-FB296306-24F2-44B8-B8D3-8F4D5A297638 @default.
- Q37698957 P304 Q37698957-090E8572-F944-405A-843E-37B7E4DDE399 @default.
- Q37698957 P31 Q37698957-6D408FCC-747A-492B-B6C5-8CF6091BC556 @default.
- Q37698957 P356 Q37698957-DBF94D09-3EC9-4CB0-8936-378C96D91EE3 @default.
- Q37698957 P407 Q37698957-675E0944-9305-47F7-9BFF-170F822CB5C2 @default.
- Q37698957 P433 Q37698957-D15D0A61-8899-4DDD-A852-9FFE2A9C69B5 @default.
- Q37698957 P478 Q37698957-4D78B091-4846-471C-98D4-A76C31FF0443 @default.
- Q37698957 P50 Q37698957-10A4D29D-1A14-4F76-A6E8-B7048A4A6CE4 @default.
- Q37698957 P577 Q37698957-1244B743-8E68-478A-918E-82FA716F8051 @default.
- Q37698957 P5875 Q37698957-81895A49-C49B-47A5-BF65-0A19F67CF1E1 @default.
- Q37698957 P698 Q37698957-3BE32ABE-4E42-4B5F-B46D-0BE59F95CCC1 @default.
- Q37698957 P921 Q37698957-13AF070D-6B4A-4D8A-A389-3368D6041613 @default.
- Q37698957 P921 Q37698957-F7EBF95C-5D71-448B-874D-5F905F9BC776 @default.
- Q37698957 P921 Q37698957-FC7CB10A-A8E7-492C-AA7B-82C983598671 @default.
- Q37698957 P932 Q37698957-7EA770C4-2035-4FD1-8B50-C1A7E10C4018 @default.
- Q37698957 P356 MABS.27756 @default.
- Q37698957 P698 24492307 @default.
- Q37698957 P1433 Q6714645 @default.
- Q37698957 P1476 "Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models" @default.
- Q37698957 P2093 "Alyssa LaBelle" @default.
- Q37698957 P2093 "Charlene A Audette" @default.
- Q37698957 P2093 "Christina N Carrigan" @default.